Nephrology Grand Rounds: SGLT2 Inhibitors
1:06:22
EMPA KIDNEY results: Flozins for all CKD with Dr Will Herrington
26:36
Professor Christoph Wanner - Renoprotective effects of SGLT2 inhibitors
59:59
The Aging Kidney with Dr Andrew Rule
25:32
Dr Julie Lovshin - SGLT2i Cardiorenal mechanisms in diabetes and beyond
13:17
ESC 2020 Discussion: The DAPA-CKD Study — Prof David Wheeler & Dr Harriette Van Spall
16:37
SGLT2 INHIBITORS Mechanism of action Side effects
56:22
"SGLT2 Inhibitors: Mechanisms of Behind the Mortality Benefit" presented by Amy Li
13:49